Company Description:

NorthStar Medical Radioisotopes, LLC was founded to address the needs of the nuclear medicine market in the United States. A wholly owned subsidiary of NorthStar Medical Technologies LLC, the company is committed to resolving industry-wide supply challenges that have caused shortages of vital medical isotopes, negatively impacting patient care and stalling clinical research. Its patented technologies include innovative non-uranium based molybdenum-99 production methods, a novel separation chemistry system and tools for the nuclear medicine market.

NorthStar is expanding rapidly as we progress toward approval and market introduction of our initial product offering.  Our first products are Non-HEU 99-Molybdenum and our revolutionary RadioGenix intelligent isotope separation system.  NorthStar will be the first domestic producer of 99-Molybdenum in over 25 years and the only supplier of Non-HEU material.  Our paradigm shifting RadioGenix technology platform represents a true evolutionary step in isotope availability and ensures a pipeline of future products to diagnose and treat disease.

NorthStar is a customer focused medical company utilizing a cross functional team approach to solving the unique challenges encountered routinely with cutting edge technology.  If you enjoy an intelligent team approach and an energized atmosphere, you may have the potential to be part of the NorthStar team.